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Abstract 
Background: Proteins produced by bacteriophages can have potent antimicrobial activity. The study of phage-host 
interactions can therefore inform small molecule drug discovery by revealing and characterising new drug targets. 
Here we characterise in silico the predicted interaction of gene protein 0.4 (GP0.4) from the Escherichia coli (E. coli) 
phage T7 with E. coli filamenting temperature-sensitive mutant Z division protein (FtsZ). FtsZ is a tubulin homolog 
which plays a key role in bacterial cell division and that has been proposed as a drug target.
Results: Using ab initio, fragment assembly structure modelling, we predicted the structure of GP0.4 with two 
programs. A structure similarity-based network was used to identify a U-shaped helix-turn-helix candidate fold as 
being favoured. ClusPro was used to dock this structure prediction to a homology model of E. coli FtsZ resulting in a 
favourable predicted interaction mode. Alternative docking methods supported the proposed mode which offered 
an immediate explanation for the anti-filamenting activity of GP0.4. Importantly, further strong support derived from 
a previously characterised insertion mutation, known to abolish GP0.4 activity, that is positioned in close proximity to 
the proposed GP0.4/FtsZ interface.
Conclusions: The mode of interaction predicted by bioinformatics techniques strongly suggests a mechanism 
through which GP0.4 inhibits FtsZ and further establishes the latter’s druggable intrafilament interface as a potential 
drug target.
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Background
Resistance to antibiotics has become a source of great 
public concern recently, compounded by the slow emer-
gence of new antibiotics [1]. One possible solution may 
be phage therapy. Bacteriophages (referred to hereafter 
as phages) are among the simplest and most abundant 
types of microorganisms [2], and have been used thera-
peutically for close to a century. With the advent of anti-
biotics, the use of phages therapeutically has decreased in 
the western world. However, as resistance to antibiotics 
becomes a pressing issue, phages are once again being 
seen as a way to combat disease [3, 4].
There are several advantages to the therapeutic use of 
phages; they affect highly specific targets that minimise 
collateral damage [5], they can target bacterial strains 
resistant to antibiotics, and they can be used to sup-
plement the effects of antibiotics [6]. Phages are, how-
ever, not without problems. For example, the delivery 
of phages is a major challenge, with the immune sys-
tem presenting a large hurdle [3] and the use of phages 
as a delivery method requires accurate diagnosis of 
the disease-causing bacteria and therefore slows down 
treatment.
Study of phage-host interaction can also inform small 
molecule drug discovery by revealing new drug targets 
and pinpointing their weaknesses. Proteins in phages 
have naturally evolved to find effective methods to dis-
rupt bacteria. Furthermore, in multi-protein complexes 
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involved in processes such as cell regulation, small num-
bers of amino acids form hotspots which contribute most 
of the free energy during interactions [7]. By studying 
how phage proteins disrupt the protein–protein inter-
faces, we can identify potential hotspots and target them 
when designing drugs. Such drugs would dispense with 
the specificity limitation of the original phage since they 
can be designed to target broadly conserved bacterial 
mechanisms potentially rendering unnecessary the diag-
nosis of the specific pathogenic bacterium [8, 9].
Upon infection of bacteria, phages take over the host 
resources through the actions of proteins expressed early 
in the infection. One such protein from the Escherichia 
coli phage T7 is gene protein (GP) 0.4. GP0.4 directly 
inhibits the filamenting temperature-sensitive mutant Z 
division protein (FtsZ) of E. coli by preventing its assem-
bly into protofilaments both in vivo and in vitro [10].
FtsZ is a tubulin homologue that plays a key role in 
the division of bacteria cells [11–13]. Much like tubu-
lin, purified FtsZ binds and hydrolyses GTP [13]. GTP 
binding induces the FtsZ to polymerise into one of two 
polar protofilament conformations; straight or gently 
curved [11–15]. Between FtsZ monomers, an active site 
is formed which hydrolyses the GTP, and remains acces-
sible to the GTP-rich cytoplasm [13, 15]. Therefore GTP 
binding can be rapidly restored allowing protofilaments 
to consist of mostly FtsZ-GTP subunits resistant to 
depolymerisation [13]. The FtsZ protofilaments associate 
laterally to form bundles or sheets [11, 13]. As the proto-
filaments bundle together they form the Z ring at the site 
of cytokinesis. Once assembled, the Z ring plays a crucial 
role in recruiting downstream proteins essential for cell 
division [12, 13]. Therefore the inhibition of FtsZ poly-
merisation prevents the division of the bacteria [10].
The exact mechanism through which GP0.4 interacts 
with FtsZ is unknown. However, a mutation in FtsZ that 
introduced a six nucleotide insertion (TCGGCG) over-
came the toxicity of GP0.4 [10]. Here, using a suite of 
structural bioinformatics methods, we predict the struc-
ture of GP0.4 ab initio and determine a mode of interac-
tion with FtsZ in accord with available data. The results 
suggest that the FtsZ protofilament interface is targeted 
in different ways by phage proteins for antimicrobial pur-
poses or by the bacteria’s own proteins for regulatory 
purposes. These results add weight to the notion that this 
pocket is a druggable interface.
Methods
Sequence analysis
BLAST [16] was used with the GP0.4 and FtsZ sequences 
to identify homologous proteins in the UniProt database 
[17] and to search for any homologues already structur-
ally characterised in the Protein Data Bank (PDB) [18]. 
The HHPred server was used to confirm that the struc-
ture of GP0.4 could not be inferred by distant homology 
to any known structure.
GP0.4 ab initio modelling
To elucidate a structure for GP0.4, ROSETTA 3.5 Abi-
nitioRelax modelling [19–24] was used. The Abinitio-
Relax application consists of two steps; the first step is 
a coarse-grained fragment-based search for conforma-
tion that uses a score function which favours protein-like 
features (Abinitio). The second step is an all atom refine-
ment using the Rosetta full-atom force field (Relax). The 
Robetta server [22, 25] was used to generate the required 
fragments and the PSIPRED [26] secondary structure 
predictions used by ROSETTA.
Using ROSETTA, 10,000 ab  initio models (or decoys) 
were produced for GP0.4 and clustered using default 
protocols on a Linux workstation. Representatives of the 
largest ten resulting clusters were considered as candi-
date fold predictions. This process was repeated for four 
homologues identified in the BLAST search. In addition 
to ROSETTA, GP0.4 and each homologous sequence was 
submitted to the QUARK ab  initio server [27]. QUARK 
is an ab initio modelling method conceptually similar to 
ROSETTA. The server yielded a further ten models (rep-
resentatives of the ten largest clusters) for each of the 
proteins.
Validation and comparison of GP0.4 models
GROMACS 5.0.1 molecular dynamics [28–32] was used 
to test the stability of the models over a period of 5  ns 
using a cubic box filled with water as the solvent, chloride 
as the counterions, and the AMBER99SB-ILDN force 
field [33]. ProSA [34, 35] and QMEAN [36–39] were used 
to obtain protein structure quality measurements.
The top ten models produced for each protein by 
ROSETTA and QUARK were submitted to the ProCKSI 
comparative server [40] to assess any structural similarity 
between them by producing a matrix of template mod-
elling (TM) scores [41]. This matrix was visualised using 
CLuster ANalysis of Sequences (CLANS) [42] to cluster 
the models with an attraction value of >0.6.
FtsZ comparative modelling
ROSETTA comparative modelling (RosettaCM) [25] 
was used to make ten models of E. coli FtsZ based on ten 
homologues (2VAW, 2VXY, 4M8I, 1RQ2, 1OFU, 1W5F, 
2VAP, 2R75, 3J4S and 4B45) obtained from HHPred 
[43–45]. RosettaCM optimises an all-atom energy func-
tion over the conformational space defined by homo-
logue structures to produce models with more accurate 
side chain and backbone conformations than previously 
available. In order to select the best model produced, the 
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inbuilt RosettaCM scoring system was used in combina-
tion with the model quality assessment program ProSA 
[34, 35].
Docking
Four servers that performed well in the most recent 
CAPRI (Critical Assessment of PRediction of Interac-
tions) competition [46] were used to predict how mod-
els of FtsZ and GP0.4 might interact—ClusPro [47–50], 
Swarmdock [51–53], Dock/PIERR [54] and GRAMM-X 
[55].
The final putative GP0.4 binding site was assessed for 
drugability with two complementary servers (DoG-
siteScorer [56] and FTMap [57–59]) and its conserva-
tion between FtsZ sequences quantified with ConSurf 
[60–63].
Results and discussion
ab initio modelling of GP0.4
Since fragment-based ab  initio modelling can benefit 
from consideration of homologous sequences, rather 
than focusing exclusively on the target, a BLAST [16] 
search with GP0.4 was done and identified four complete, 
non-redundant homologues in other phages (Fig.  1), 
none of which had been characterised.
Fragment-based ab  initio modelling was done locally 
using ROSETTA [19–24] and remotely at the QUARK 
server [27] producing ten models (cluster centroids) 
each for GP0.4 itself (UniProt accession P03776), and 
homologues in Yersinia phage YpsP-R (I6Q992), Salmo-
nella phage Vi06 (E1XU80), and Citrobacter phage CR8 
(W6PPJ7). In order to look for consensus among the 100 
model set, clustering was carried out based on pairwise 
TM scores obtained from the ProCKSI server [40]. TM 
scores are a well-established method to quantitatively 
measure the structural difference between two proteins 
[41] and range between 0 and 1: randomly chosen struc-
tures have an average score of 0.17 while a score of over 
0.5 is considered as indicating that the two proteins have 
the same fold. Figure  2 shows GP0.4 and homologue 
models (nodes) linked by lines indicating a shared TM 
score of >0.6. This produced two clusters of note, one 
considerably larger than the other.
The larger cluster, containing ‘U’-shaped models was 
made up of QUARK predictions for GP0.4 and homo-
logues from phages YpsP-R, Vi06 and CR8, along with 
Rosetta models for Vi06 and YpsP-R. The smaller and 
therefore less favoured cluster contained Rosetta mod-
els for GP0.4 and the CR8 homologue which were ‘V’-
shaped. From each cluster, the GP0.4 model which made 
the most links to other structures was selected as a repre-
sentative model for further analysis (Fig. 3). GROMACS 
[28–32] molecular dynamics was used to test the stability 
of these models and found both stabilize at low structural 
deviation (<1.75 Å rmsd on Cα atoms) from the starting 
structure within 5  ns. Similarly, model quality assess-
ment with ProSA [34, 35] and QMEAN [36–39] did not 
favour one model or the other: within each cluster struc-
tures were found with ProSA scores as low as −4.36 and 
QMEAN scores as high as 0.734, within the range seen 
for experimental protein structures of a similar size. Fur-
thermore, searches of the PDB using PDBeFOLD [68] 
and DALI [69] did not identify any significantly similar 
structures to either of the two GP0.4 models.
FtsZ modelling
RosettaCM [25] was used to produce ten models of E.coli 
FtsZ using homologous structures from P. aeruginosa 
(1ofu, 2vaw), M. tuberculosis (1rq2), T. maritima (1w5f), 
A. aeolicus (2r75), M. jannaschii (2vap), B.subtilis (2vxy), 
B. thuringiensis (3j4 s), H. volcanii (4b45) and S. epider-
midis (4m8i) as templates. FtsZ has a well conserved core 
domain followed by a variable C-terminal domain (Addi-
tional file 1: Figure S1). Indeed the ten models produced 
were very similar apart from that variable C-terminal 
domain which adopted a wide variety of poorly packed 
Fig. 1 The alignment of GP0.4 (Uniprot accession: P03776), Yersinia phage YpsP-R (I6Q992), Salmonella phage Vi06 (E1XU80), and Citrobacter phage 
CR8 (W6PPJ7) using multiple sequence comparison by Log- Expectation (MUSCLE) [64, 65], and coloured using the Clustal colour scheme in 
Jalview [66]. The PSIPRED [67] secondary structure prediction for GP0.4 used in the ab initio modelling is shown below: red bars represent predicted 
α-helices and green arrows represent predicted β-strands
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conformations. Previous studies of FtsZ–FtsZ interac-
tion found that the C-terminal domain was not required 
for the assembly of protofilaments, but was essential for 
interaction with other membrane associated cell division 
proteins [13]. Since our focus here was on the inter-sub-
unit interface of the protofilament targeted by GP0.4, the 
C-terminal region was eliminated and RosettaCM energy 
scores and ProSA [34, 35] scores were used to identify 
the most favoured model of the core domain.
Docking
Initial docking experiments between the GP0.4 ‘U’ and 
‘V’ models and the FtsZ model were performed using the 
ClusPro server [47–50]. The ‘U’ and the ‘V’ model were 
predicted to bind to two different locations using default 
(‘balanced’) settings. The docking site for the ‘U’ model 
was obtained from a cluster of 280/1000 models, and the 
docking site for the ‘V’ model was obtained from a clus-
ter of 382/1000 models. The ‘V’ model bound to a region 
flanked by H6, H7 and S7, whereas the more favoured 
‘U’ model bound to a region flanked by H1, H5 and H7 
(Fig. 4).
The results from ClusPro [47–50] were compared to 
those obtained using Swarmdock [51–53], Dock/PIERR 
[54] and GRAMM-X [55]. For the ‘U’ shaped model the 
top prediction from Dock/PIERR and the 6th highest 
prediction from Swarmdock were found to match the top 
prediction from ClusPro (Fig.  5). GRAMM-X also pre-
dicted that GP0.4 would bind to the same region of FtsZ 
but predicted a different docking pose (not shown).
In contrast, there was little agreement between the 
docking server results for the ‘V’ shaped model. For 
example, there was no coincidence between any of the top 
ten predictions from ClusPro, Dock/PIERR or Swarm-
dock. The lack of a consensus in the ‘V’ shaped model 
docking results is further indirect evidence supporting 
the ‘U’-shaped model since consistency between docking 
results would be expected of reliable results. Further sup-
port for the docking predictions for the ‘U’-shaped model 
Fig. 2 Clustering by pairwise TM scores of models of GP0.4 (UniProt accession number: P03776), Yersinia phage YpsP-R (I6Q992), Salmonella phage 
Vi06 (E1XU80), and Citrobacter phage CR8 (W6PPJ7). Each point represents a model, coloured by origin blue (Rosetta) or red (QUARK). Shapes indicate 
the sequence modelled: square GP0.4 (P03776), triangle YpsP-R (I6Q992), circle Vi06 (E1XU80) and diamond CR8 (W6PPJ7). Lines indicate TM scores of 
>0.6. The figure was made using CLANS [42]
Fig. 3 Comparison of GP0.4 models from the major (a ‘U’-shaped) 
and minor (b ‘V’-shaped) clusters in Fig. 2. Each is coloured from 
N-(blue) to C-terminus (red) as a spectrum. Visualised in PyMOL 
Molecular Graphics System, Version 1.7.4 Schrödinger, LLC. PyMOL 
was also used for Figs.  4, 5, 6 and 7
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is obtained by considering the FtsZ protofilament. The 
‘U’-shaped model inserts its well-conserved central helix-
turn-helix motif into a cleft between helices 1, 5 and 7 on 
FtsZ thereby preventing formation of a further intrafila-
ment interface (Fig. 6). The conserved FtsZ residues G21, 
N24, G47 and G107 contribute to the binding by mak-
ing hydrogen bond interactions with GP0.4. Given that 
the consensus ‘U’-shaped model offered such a plausible 
explanation for the anti-filamenting activity of GP0.4, 
attention was then focussed exclusively on it, excluding 
the ‘V’-shaped complex from further consideration.
Mutant Ftsz modelling
Kiro et al. [10] identified a GP0.4 resistant variant of FtsZ, 
FtsZ9, where a 6 nucleotide insertion (TCGGCG) at posi-
tion 18 resulted in a duplication of glycine–valine that 
allowed FtsZ9 to overcome the toxicity of GP0.4. It was 
reasoned that modelling this mutation might help iden-
tify how and where GP0.4 interacts with FtsZ. As shown 
in Fig. 7, the site of the mutation lies exactly at the base of 
the cleft to which GP0.4 is predicted to bind. This offers 
strong support to the binding model since the additional 
two residues encoded by FtsZ9 are thus perfectly placed 
to impeded GP0.4 binding and thereby confer resistance 
on the bacterium. The mutation also lies near the guanine 
nucleotide binding side of FtsZ, and the data of Kiro et al. 
[10] suggest that nucleotide binding is unaffected. How-
ever, we were unable to model a mutant FtsZ structure in 
which guanine nucleotides bound in the canonical fash-
ion: conceivably, nucleotide binding is maintained in an 
altered fashion in FtsZ9.
Interestingly, MciZ, a developmental regulator of bac-
terial cell division was found to inhibit FtsZ polymeri-
sation by targeting the same region of the intrafilament 
FtsZ interface as GP0.4 whilst binding to the opposite 
face of the FtsZ monomer [70], as shown in Fig. 6.
Characteristics of the predicted GP0.4 binding site
To help identify whether our putative GP0.4 binding 
pocket is a suitable candidate for small molecule drug 
design we used druggability servers; DoGsiteScorer [56] 
which looks for properties shared with known drug pock-
ets and FTMap [57–59] which identifies areas bound by 
small organic probe molecules. The druggability servers 
both identified our pocket as a suitable biological target 
for drug binding (Fig. 8).
In order to assess whether the druggable predicted 
GP0.4 binding site is conserved among bacteria, we 
mapped sequence conservation of 150 FtsZ sequences 
onto the FtsZ structure using the ConSurf server. Figure 8 
shows that the area the ‘U’ model bound to was well con-
served. This provides evidence that a GP0.4 like protein or 
small molecule targeted to its binding site might be effec-
tive against FtsZ in other bacteria including pathogenic 
species: indeed, GP0.4 homologues were identified in 
phages for Yersinia and Salmonella supporting this idea.
Fig. 4 The top results when docking the ‘V’ form (a) and the ‘U’ form (b) of GP0.4 to the FtsZ model in ClusPro [47–50]. The GP0.4 model is coloured 
blue while the FtsZ structure is coloured by secondary structure: red for α-helices, yellow for β-strands, green for coil. Regular secondary structure 
elements in FtsZ are labelled H for α-helices or S for β-strands. The α-helices (H) and β-strands (S) shown in the cartoon representation of FtsZ are 
labeled according to the 3D structures of Methanococcus jannaschi FtsZ
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Fig. 5 Cross-eyed stereo view of the consensus in docking of the ‘U’ form using ClusPro (Blue), Swarmdock (Magenta) and Dock/PIERR (Green). The 
FtsZ structure is coloured by secondary structure: red for alpha helix, yellow for beta sheet, green for coil
Fig. 6 a The interaction between an upper FtsZ (Red) monomer and a lower FtsZ (Green) monomer in a protofilament. b the locations at which 
GP0.4 (Blue) binds to the lower FtsZ (Green) monomer and MciZ (Purple) binds to the upper FtsZ (Red) monomer. These can be seen to target the 
same region of the interface
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The FtsZ filament interface targeted by GP0.4 has pre-
viously been highlighted as a possible target for small 
molecule targeting. However, there are concerns over tar-
geting the GTP-binding site due to a risk of poisoning the 
eukaryotic homologue, tubulin [71]. Nevertheless, our 
results emphasise the druggable nature of a larger inter-
face including the pocket targeted by GP0.4 They there-
fore encourage further efforts at exploiting the interface 
for small molecule drug design as well as offering possi-
ble routes forward for peptidomimetic inhibition.
Conclusions
Characterising the targets and inhibitory mechanisms 
of phage proteins is a valuable route to the discov-
ery and validation of new potential drug targets. Here 
we bring a range of structural bioinformatics meth-
ods to bear on the interaction between phage GP0.4 
and its bacterial target FtsZ. We provide evidence that 
GP0.4 adopts a ‘U’ shaped conformation that inserts 
into a cleft between helices 1, 5 and 7 on FtsZ. The 
hypothesis is strongly supported by data obtained for 
Fig. 7 An enhanced view of the docked GP0.4. Interaction between GP0.4 (blue) and FtsZ residues N24 (2.8 Å), L178 (5.2 Å), and F182 (4.6 Å) are 
shown as lines. The orange circle indicates the location at where the mutation is inserted
Fig. 8 a The highest ranked drug pocket predicted by DoGsiteScorer (mauve) coincides with the putative GP0.4 binding site (GP0.4 surface shown 
as transparent grey). b The second highest ranked location of ligand binding predicted by FTMap (magenta) again coincides with the putative GP0.4 
binding site (grey). In (a) and (b) FtsZ is coloured by secondary structure: red for alpha helix, yellow for beta sheet, green for coil. c ConSurf results 
indicating FtsZ amino acid conservation on a scale of blue to red, where blue is most conserved and red is least conserved
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a GP0.4-resistant FtsZ mutation [10]. The presence of 
GP0.4 bound to this region, as shown in Fig.  6, would 
physically interfere with assembly of the FtsZ filament. 
The importance of this FtsZ–FtsZ interface was further 
demonstrated by MciZ, a regulatory protein that binds 
to the opposite side of the interface to inhibit bacterial 
cell division. The druggable nature of the broad intra-
filament FtsZ interface should encourage future drug 
design.
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